Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-02 4:30 pm Purchase | 2022-11-22 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | RA CAPITAL MANAGEMENT L.P. | 4,333,333 5.290% | 4,333,333![]() (New Position) | Filing History |
| 2022-12-02 4:24 pm Purchase | 2022-11-22 | 13D | NEWAMSTERDAM PHARMA CO NV SHS NAMS | BCLS II Investco, LP | 4,000,000 4.900% | 4,000,000![]() (New Position) | Filing History |
| 2022-12-02 4:05 pm Purchase | 2022-11-22 | 13G | FRAZIER LIFESCIENCES ACQ CORP FLAC | Morningside Venture Investments Ltd | 5,065,846 6.210% | 5,065,846![]() (New Position) | Filing History |
| 2022-12-02 06:01 am Purchase | 2022-11-22 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | AMGEN INC AMGN | 4,910,000 6.000% | 4,910,000![]() (New Position) | Filing History |
| 2022-12-01 5:33 pm Purchase | 2022-11-22 | 13D | NEWAMSTERDAM PHARMA CO NV SHS NAMS | Frazier Lifesciences Sponsor LLC | 9,801,333 12.000% | 9,801,333![]() (New Position) | Filing History |
